MARKET

GURBF

GURBF

Guerbet Sa
OTCPK
32.00
NaN%
Closed 09:30 02/13 EST
OPEN
--
PREV CLOSE
32.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
58.35
52 WEEK LOW
32.00
MARKET CAP
403.68M
P/E (TTM)
66.92
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GURBF last week (0908-0912)?
Weekly Report · 09/15/2025 12:41
Weekly Report: what happened at GURBF last week (0901-0905)?
Weekly Report · 09/08/2025 12:42
Weekly Report: what happened at GURBF last week (0825-0829)?
Weekly Report · 09/01/2025 12:34
Weekly Report: what happened at GURBF last week (0818-0822)?
Weekly Report · 08/25/2025 12:53
About GURBF
Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The Company operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Webull offers Guerbet SA stock information, including OTCPK: GURBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GURBF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GURBF stock methods without spending real money on the virtual paper trading platform.